Omadacycline

Analogue of vasopressin used as a vasoactive drug in the management of low blood pressure. It has been found to be effective when norepinephrine does not help.

Indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response or intolerance to methotrexate. It may be used as monotherapy or in combination with methotrexate or other nonbiologic disease-modifying antirheumatic drugs...

For the synchronization of time of insemination in weaned sows to facilitate a single fixed-time artificial insemination.

Indicated for patients with hemophilia A with factor VIII coagulant activity levels greater than 5%.

Indicated for the treatment of adults with metastatic basal cell carcinoma, or with locally advanced basal cell carcinoma that has recurred following surgery or who are not candidates for surgery and who are not candidates for radiation.

Micafungin Sodium, Anidulafungin-Fructose, Dalbavancin, Everolimus, Sarecycline, Midostaurin etc.

Indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus ,  to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction or non-fatal stroke) in adults with type 2 diabetes mellitus and est...

Rezafungin is a next-generation, semi-synthetic, cyclic lipopeptide and echinocandin derivative, with potential antifungal activity. 

Glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. 

Indicated for the inhibition of premature LH surges in women undergoing controlled ovarian stimulation.

Indicated for treatment of patients with advanced prostate cancer.

Indicated in Psoriatic Arthritis, Psoriasis and Oral Ulcers Associated with Behçet’s Disease

Brochure of the company for referring to Company's work profile, strengths, capabilities and facility information.